McEntee JE - Search Results

1

A survey of UK dental health professionals using a medicines information service: what questions do they ask and do they get useful answers?

McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ, Randall CJ. McEntee JE, et al. Br Dent J. 2011 Jul 8;211(1):17-21. doi: 10.1038/sj.bdj.2011.522. Br Dent J. 2011. PMID: 21738182

2

Utility and value of a medicines information service provided by pharmacists: a survey of health professionals.

McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ. McEntee JE, et al. Int J Pharm Pract. 2010 Dec;18(6):353-61. doi: 10.1111/j.2042-7174.2010.00068.x. Int J Pharm Pract. 2010. PMID: 21054596

3

Dental local anaesthetics and latex: advice for the dental practitioner.

McEntee J. McEntee J. Dent Update. 2012 Sep;39(7):508-10. doi: 10.12968/denu.2012.39.7.508. Dent Update. 2012. PMID: 23094572

4

Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Dwan K, Beale S, Fleeman N, McEntee J, Dundar Y, Richardson M, Fisher M. Greenhalgh J, et al. Health Technol Assess. 2015 Apr;19(29):1-130. doi: 10.3310/hta19290. Health Technol Assess. 2015. PMID: 25896573 Free PMC article. Review.

5

Payer and Implementation Challenges with Advanced Therapy Medicinal Products (ATMPs).

Spoors J, Miners A, Cairns J, Palnoch D, Summerfield A, McEntee J, Vithlani S. Spoors J, et al. BioDrugs. 2021 Jan;35(1):1-5. doi: 10.1007/s40259-020-00457-4. BioDrugs. 2021. PMID: 33226582

6

EU rules on formulations containing sodium.

McEntee JE. McEntee JE. BMJ. 2014 Feb 5;348:g1289. doi: 10.1136/bmj.g1289. BMJ. 2014. PMID: 24500348 No abstract available.

7

Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.

Fleeman N, Houten R, Nevitt S, Mahon J, Beale S, Boland A, Greenhalgh J, Edwards K, Maden M, Bhattacharyya D, Chaplin M, McEntee J, Chow S, Waddell T. Fleeman N, et al. Health Technol Assess. 2024 Aug;28(49):1-190. doi: 10.3310/TRRM4238. Health Technol Assess. 2024. PMID: 39252678 Free PMC article.

8

Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Fleeman N, Abdulla A, Bagust A, Beale S, Richardson M, Stainthorpe A, Boland A, Kotas E, McEntee J, Palmer D. Fleeman N, et al. Pharmacoeconomics. 2018 Mar;36(3):289-299. doi: 10.1007/s40273-017-0592-3. Pharmacoeconomics. 2018. PMID: 29178025 Review.

9

Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Lambe T, Duarte R, Mahon J, Nevitt S, Greenhalgh J, Boland A, Beale S, Kotas E, McEntee J, Pomeroy I. Lambe T, et al. Pharmacoeconomics. 2019 Mar;37(3):345-357. doi: 10.1007/s40273-018-0718-2. Pharmacoeconomics. 2019. PMID: 30328051 Free PMC article. Review.

10

Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Fleeman N, Bagust A, Duarte R, Richardson M, Nevitt S, Boland A, Kotas E, McEntee J, Thorp N. Fleeman N, et al. Pharmacoecon Open. 2019 Sep;3(3):293-302. doi: 10.1007/s41669-018-0114-z. Pharmacoecon Open. 2019. PMID: 30742256 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters